Arnaud MAURAC

March 2026 European Respiratory Journal

Severe hypoxaemia and intrapulmonary vascular dilatations associated with long-term luspatercept therapy

Authors : Marina Gueçamburu, Pierre Schilfarth, Xavier Demant, Sophie Dimicoli-Salazar, Aurélien Lamor-Fauthoux, Marc Humbert, David Montani, Christophe Guignabert, Laurent Savale, Arnaud Maurac

May 2025 CHEST

Association of Pulmonary Hypertension With Trastuzumab Emtansine

Authors : Camille Poisson, Alex Hlavaty, Nicolas Favrolt, Marie-Camille Chaumais, Julien Grynblat, Etienne-Marie Jutant, Benoît Lechartier, Arnaud Maurac, Pierre Mouillot, Sylvain Palat, Laurie Rambach, Fabrice Antigny, Vincent Cottin, Guillaume Beltramo, Marc Humbert, Charles Khouri, Philippe Bonniaud, David Montani

May 2022 Respiratory Medicine and Research

Progression to a severe form of COVID-19 among patients with chronic respiratory diseases

Authors : Sarah Basin, Simon Valentin, Arnaud Maurac, Mathias Poussel, Benjamin Pequignot, Aurélien Brindel, Guillaume Poupet, Céline Robert, Cédric Baumann, Amandine Luc, Julien Soler, François Chabot, Ari Chaouat

August 2019 European Respiratory Journal

T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease

Authors :

April 2019 BMJ Case Reports

Thoracic involvement of diffuse lymphangiomatosis successfully treated with sildenafil

Authors :

Members

Arnaud MAURAC

Publications 5

Severe hypoxaemia and intrapulmonary vascular dilatations associated with long-term luspatercept therapy

Association of Pulmonary Hypertension With Trastuzumab Emtansine

Progression to a severe form of COVID-19 among patients with chronic respiratory diseases

T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease

Thoracic involvement of diffuse lymphangiomatosis successfully treated with sildenafil

Team

Pathophysiology of the pulmonary circulation